These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 11046128)

  • 1. Selection of alternative 5' splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1.
    Eperon IC; Makarova OV; Mayeda A; Munroe SH; Cáceres JF; Hayward DG; Krainer AR
    Mol Cell Biol; 2000 Nov; 20(22):8303-18. PubMed ID: 11046128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1.
    Chabot B; Blanchette M; Lapierre I; La Branche H
    Mol Cell Biol; 1997 Apr; 17(4):1776-86. PubMed ID: 9121425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
    Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM
    Mol Carcinog; 2004 Dec; 41(4):187-96. PubMed ID: 15390079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U1 snRNP-ASF/SF2 interaction and 5' splice site recognition: characterization of required elements.
    Jamison SF; Pasman Z; Wang J; Will C; Lührmann R; Manley JL; Garcia-Blanco MA
    Nucleic Acids Res; 1995 Aug; 23(16):3260-7. PubMed ID: 7667103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse nuclear RNAi-defective 2 promotes splicing of weak 5' splice sites.
    Flemr M; Schwaiger M; Hess D; Iesmantavicius V; Ahel J; Tuck AC; Mohn F; Bühler M
    RNA; 2023 Aug; 29(8):1140-1165. PubMed ID: 37137667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
    Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
    PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of 5' splice-sites through multiple exonic motifs by hnRNP L.
    Loh TJ; Choi N; Moon H; Jang HN; Liu Y; Zhou J; Zheng X; Shen H
    Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):363-373. PubMed ID: 28119102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SRp30c is a repressor of 3' splice site utilization.
    Simard MJ; Chabot B
    Mol Cell Biol; 2002 Jun; 22(12):4001-10. PubMed ID: 12024014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1.
    Rooke N; Markovtsov V; Cagavi E; Black DL
    Mol Cell Biol; 2003 Mar; 23(6):1874-84. PubMed ID: 12612063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.
    Mayeda A; Krainer AR
    Cell; 1992 Jan; 68(2):365-75. PubMed ID: 1531115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF.
    Eperon IC; Ireland DC; Smith RA; Mayeda A; Krainer AR
    EMBO J; 1993 Sep; 12(9):3607-17. PubMed ID: 8253084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles and correction of 5'-splice site selection.
    Malard F; Mackereth CD; Campagne S
    RNA Biol; 2022 Jan; 19(1):943-960. PubMed ID: 35866748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
    Zhu J; Mayeda A; Krainer AR
    Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
    Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
    J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells.
    Krainer AR; Conway GC; Kozak D
    Genes Dev; 1990 Jul; 4(7):1158-71. PubMed ID: 2145194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of hnRNP H and U2AF65 to respective G-codes and a poly-uridine tract collaborate in the N50-5'ss selection of the REST N exon in H69 cells.
    Ortuño-Pineda C; Galindo-Rosales JM; Calderón-Salinas JV; Villegas-Sepúlveda N; Saucedo-Cárdenas O; De Nova-Ocampo M; Valdés J
    PLoS One; 2012; 7(7):e40315. PubMed ID: 22792276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.
    Cáceres JF; Stamm S; Helfman DM; Krainer AR
    Science; 1994 Sep; 265(5179):1706-9. PubMed ID: 8085156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of cis- and trans-acting factors supporting noncanonical splice site activation.
    Erkelenz S; Poschmann G; Ptok J; Müller L; Schaal H
    RNA Biol; 2021 Jan; 18(1):118-130. PubMed ID: 32693676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.